AngioDynamics (NASDAQ:ANGO) Announces Quarterly Earnings Results

AngioDynamics (NASDAQ:ANGO) posted its quarterly earnings results on Wednesday. The medical instruments supplier reported ($0.04) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.07, RTT News reports. AngioDynamics had a negative return on equity of 5.86% and a negative net margin of 83.95%. AngioDynamics updated its FY 2025 guidance to -0.380–0.340 EPS.

AngioDynamics Stock Up 1.4 %

Shares of AngioDynamics stock opened at $9.40 on Wednesday. AngioDynamics has a 12-month low of $5.26 and a 12-month high of $9.63. The stock has a market capitalization of $381.96 million, a P/E ratio of -1.54 and a beta of 0.59. The stock has a 50 day moving average price of $7.82 and a two-hundred day moving average price of $7.27.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on ANGO. HC Wainwright reaffirmed a “buy” rating and set a $14.00 price objective on shares of AngioDynamics in a research report on Tuesday, December 10th. Canaccord Genuity Group cut their price target on shares of AngioDynamics from $13.00 to $12.00 and set a “buy” rating on the stock in a report on Friday, October 4th.

AngioDynamics Company Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.